Visit https://www.peervoice.com/FRG860 to view the entire programme with slides. After completing “Optimising Outcomes With PARPs: Cases in Advanced Ovarian Cancer”, participants will be able to: Identify the diverse factors that can influence treatment decision-making in advanced ovarian cancer; Evaluate recent clinical evidence for PARP inhibitors in the management of advanced ovarian cancer; Translate current and emerging evidence into optimal treatment strategies for patients with advanced ovarian cancer